Before the COVID-19 pandemic, for-profit nursing homes’ revenue generally covered their costs, whereas not-for-profit nursing homes often needed donations and other nonpatient revenue to cover ...

Biosimilars present a key opportunity to contain the growing cost of biologic drug spending and to make essential medications more affordable. However, the lackluster performance of the US biosimilar ...

The NIH’s current system for funding scientific research perpetuates health disparities by privileging established, well-resourced institutions and reinforcing an individual-level focus on disease ...

The policies proposed by Project 2025, if implemented, could fundamentally reshape not only the landscape of reproductive ...

Regulation of health system consolidation should take into account all aspects of the market for health care goods and ...

Instead of abolishing health savings accounts, we could turn them into vehicles for patients to get more cost-effective, ...

The sweeping relief sought by plaintiffs could erode protections for consumers against unanticipated financial liabilities ...

Using the analogy of chess, we suggest tobacco control in the US has reached an endgame phase, during which public health ...

In anticipation of the end of the COVID-19 public health emergency, Congress ended the Medicaid continuous coverage ...

Contrary to ACA opponents’ overhyped worries, health care cost growth has fallen through coverage expansions since the late ...

To support public health efforts and prepare for future pandemics, immunization information systems require long-term ...